Sham (Placebo) Surgery

OTHER2 trials

Sponsors

Neurocrine Biosciences, Brain Neurotherapy Bio, Inc.

Conditions

Multiple System AtrophyParkinson's Disease

Phase 1

VY-AADC02 for Parkinson's Disease With Motor Fluctuations (RESTORE-1)

CompletedNCT03562494

Neurocrine BiosciencesParkinson's Disease

Start: 2018-10-17End: 2024-10-30Updated: 2024-12-10

GDNF Gene Therapy for Multiple System Atrophy

Active, not recruitingNCT04680065

Brain Neurotherapy Bio, Inc.Multiple System Atrophy

Start: 2023-10-03End: 2028-08-01Target: 9Updated: 2026-01-30

Related Papers

Magnetic resonance imaging–guided phase 1 trial of putaminal <i>AADC</i> gene therapy for Parkinson's disease

Annals of Neurology2019-02-26154 citations